NSPR PT $2 SHORT TERM my next BNGO
Updated
This is my next BNGO! please invest money you are willing to lose and i am not a financial advisor.
Fundamentals:
see comprehensive DD in reddit.
see the recent news.
-aiming for 10 billion market share in carotid stent
-partnership in china where stroke is #1 cause of death
-their stent is innovative and they have patents
-innovative israeli company and screaming for ARK!!!!!!
-FDA approved in EU soon in china and usa.
-market cap is 30 million
-outstanding shares 37 million
Technical:
we just broke out from a BULL FLAG! with ~88million volume (avg volume is 20 million in the last 10 days).
CONS: reverse split and dilution
This is my NOT so comprehensive DD so please teach me.
Fundamentals:
see comprehensive DD in reddit.
see the recent news.
-aiming for 10 billion market share in carotid stent
-partnership in china where stroke is #1 cause of death
-their stent is innovative and they have patents
-innovative israeli company and screaming for ARK!!!!!!
-FDA approved in EU soon in china and usa.
-market cap is 30 million
-outstanding shares 37 million
Technical:
we just broke out from a BULL FLAG! with ~88million volume (avg volume is 20 million in the last 10 days).
CONS: reverse split and dilution
This is my NOT so comprehensive DD so please teach me.
Trade active
Note
let's see how this plays out. we are in a accumulation phase. this might take a week. we have some insider buying, which for me takes the R/S out of the equation even though still probable. more good news should hit my updated target. this is for learning and entertainment only. i do not recommend buy, sell or hold. thank you for following.
Trade active
keeping it simple for now. the bull flag i was hoping didn't materialized. weird market if you ask me. many tickers were down 15% yet DOW only down 100 points.
back on the chart. we touched the 38% retracement. it wasn't a strong bounce but worth mentioning it.
crossing my fingers that we bounce tomorrow. added 20k shares. good luck.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.